Actively Recruiting
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
Led by Shanghai Zhongshan Hospital · Updated on 2021-05-27
120
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective, two-center, single arm phase II clinical study to evaluate safety and effectiveness of ablation therapy in the treatment of lung cancer presenting as ground-glass nodules
CONDITIONS
Official Title
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 18 and 85 years
- Ground-glass nodule diagnosed by lung CT that has not subsided after 3 months (confirmed by thin-section CT)
- Maximum diameter of ground-glass nodule is greater than 8 mm and less than 3 cm
- For single ground-glass nodule: clear progression in pure GGO or solid component of mixed nodules is 2 mm or larger
- Patients unable to tolerate surgery or have multiple nodules that cannot be fully removed by surgery, or have had surgery in the same side of the chest
- Ability to understand and comply with study requirements and provide written informed consent
You will not qualify if you...
- Participation in any drug or medical device clinical trial within one month before this trial
- Severe disease conditions
- Allergy to narcotic drugs
- Presence of other autoimmune diseases
- Dementia or cognitive impairment that prevents cooperation with researchers
- Any local treatment other than ablation received within 4 weeks before the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
Q
Qun Wang, Phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here